Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome

10.1016/j.vhri.2015.07.001

Saved in:
Bibliographic Details
Main Authors: Zhao, YJ, Khoo, AL, Lin, L, Teng, M, Wu, TS, Chan, M.Y., Lim, BP
Other Authors: MEDICINE
Format: Article
Published: Elsevier BV 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/206228
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-206228
record_format dspace
spelling sg-nus-scholar.10635-2062282024-04-17T09:53:10Z Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome Zhao, YJ Khoo, AL Lin, L Teng, M Wu, TS Chan, M.Y. Lim, BP MEDICINE antiplatelet clopidogrel cost-effectiveness prasugrel ticagrelor Acute Coronary Syndrome Adenosine Cost-Benefit Analysis Female Humans Male Markov Chains Middle Aged Platelet Aggregation Inhibitors Prasugrel Hydrochloride Singapore Ticagrelor 10.1016/j.vhri.2015.07.001 Value in Health Regional Issues 9 22-27 2021-11-16T03:04:28Z 2021-11-16T03:04:28Z 2016-05-01 2021-11-10T06:08:33Z Article Zhao, YJ, Khoo, AL, Lin, L, Teng, M, Wu, TS, Chan, M.Y., Lim, BP (2016-05-01). Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome. Value in Health Regional Issues 9 : 22-27. ScholarBank@NUS Repository. https://doi.org/10.1016/j.vhri.2015.07.001 2212-1099 2212-1102 https://scholarbank.nus.edu.sg/handle/10635/206228 Elsevier BV Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic antiplatelet
clopidogrel
cost-effectiveness
prasugrel
ticagrelor
Acute Coronary Syndrome
Adenosine
Cost-Benefit Analysis
Female
Humans
Male
Markov Chains
Middle Aged
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Singapore
Ticagrelor
spellingShingle antiplatelet
clopidogrel
cost-effectiveness
prasugrel
ticagrelor
Acute Coronary Syndrome
Adenosine
Cost-Benefit Analysis
Female
Humans
Male
Markov Chains
Middle Aged
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Singapore
Ticagrelor
Zhao, YJ
Khoo, AL
Lin, L
Teng, M
Wu, TS
Chan, M.Y.
Lim, BP
Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
description 10.1016/j.vhri.2015.07.001
author2 MEDICINE
author_facet MEDICINE
Zhao, YJ
Khoo, AL
Lin, L
Teng, M
Wu, TS
Chan, M.Y.
Lim, BP
format Article
author Zhao, YJ
Khoo, AL
Lin, L
Teng, M
Wu, TS
Chan, M.Y.
Lim, BP
author_sort Zhao, YJ
title Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
title_short Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
title_full Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
title_fullStr Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
title_full_unstemmed Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
title_sort cost-effectiveness analysis of ticagrelor and prasugrel for the treatment of acute coronary syndrome
publisher Elsevier BV
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/206228
_version_ 1800915077807734784